1. Home
  2. WHG vs PRQR Comparison

WHG vs PRQR Comparison

Compare WHG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$16.02

Market Cap

150.0M

Sector

Finance

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.53

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
PRQR
Founded
1983
2012
Country
United States
Netherlands
Employees
148
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
166.5M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
WHG
PRQR
Price
$16.02
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
9.3K
710.7K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
3.58%
N/A
EPS Growth
203.85
N/A
EPS
0.09
N/A
Revenue
$97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
$174.67
N/A
Revenue Growth
3.21
N/A
52 Week Low
$14.51
$1.33
52 Week High
$18.99
$3.10

Technical Indicators

Market Signals
Indicator
WHG
PRQR
Relative Strength Index (RSI) 47.50 42.73
Support Level $15.31 $1.51
Resistance Level $17.22 $1.58
Average True Range (ATR) 0.65 0.12
MACD -0.04 -0.00
Stochastic Oscillator 28.57 31.67

Price Performance

Historical Comparison
WHG
PRQR

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: